Kcentra Market Report 2026

Kcentra Market Overview

• The Kcentra market growth in the historic period has been driven by widespread warfarin use, high bleeding risk in anticoagulated patients • Market expansion is supported by aging population on anticoagulants, rising emergency surgical procedures • Growth Driver: Rising Prevalence Of Bleeding Disorders To Drive Market Growth • Market Trend: FDA Approval For Urgent Warfarin Reversal In Adult Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Kcentra Market?

Kcentra is a medication specifically designed for the urgent reversal of vitamin K antagonists, such as warfarin, in patients experiencing major bleeding or requiring urgent surgery. It is a prothrombin complex concentrate that provides rapid correction of clotting factors, helping to restore normal blood coagulation. Kcentra is typically administered intravenously in healthcare settings and is known for its ability to quickly reverse anticoagulation effects, reducing the risk of bleeding complications. The main indications of kcentra are an urgent reversal of warfarin therapy, treatment of acquired coagulation factor deficiency, and management of major bleeding events. Urgent reversal of warfarin therapy involves the rapid restoration of normal blood clotting function in patients at risk of bleeding, typically using vitamin K, fresh frozen plasma, or coagulation factor concentrates. The formulations are injectable formulations and lyophilized powders for reconstitution, and the patient demographics include pediatric patients, adult patients, and geriatric patients. Various distribution channels are direct sales, wholesalers and distributors, retail pharmacies, and online pharmacies, and it is used by different end users such as hospitals, outpatient surgical centers, emergency departments, and specialty clinics.

What Is The Kcentra Market Growth Forecast?

The growth in the forecast period can be attributed to aging population on anticoagulants, rising emergency surgical procedures, improved awareness of pcc benefits, expansion of trauma care centers, growth in outpatient surgical volumes. Major trends in the forecast period include rising demand for rapid anticoagulation reversal, growth in emergency hemostasis management, expansion of surgical bleeding control therapies, increased use in trauma and critical care, strengthening hospital based coagulation protocols.

Global Kcentra Market Segmentation

1) By Indication: Urgent Reversal Of Warfarin Therapy, Treatment Of Acquired Coagulation Factor Deficiency, Management Of Major Bleeding Events 2) By Formulation: Injectable Formulation, Lyophilized Powder For Reconstitution 3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients 4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 5) By End User: Hospitals, Outpatient Surgical Centers, Emergency Departments, Specialty Clinics

What Are The Drivers Of The Kcentra Market?

The rising prevalence of bleeding disorders is expected to drive the kcentra market going forward. Bleeding disorders, such as hemophilia, von Willebrand disease (VWD), and acquired coagulopathies, refer to conditions that impair the blood's ability to clot, leading to prolonged or excessive bleeding. The rising prevalence of bleeding disorders is attributed to genetic factors, improved diagnostic methods, and greater awareness, leading to better identification of cases globally. Kcentra, a prothrombin complex concentrate, is used in the treatment of bleeding disorders, particularly in patients with vitamin K antagonists or warfarin-associated bleeding. For instance, in December 2023, according to the World Federation of Hemophilia, a Canada-based international nonprofit organization, the World Bleeding Disorders Registry recorded data from 13,343 individuals with hemophilia across 119 treatment centers in 44 countries in 2023, up from 12,296 individuals across 108 centers in 42 countries in 2022. Therefore, the rising prevalence of bleeding disorders drives the kcentra industry. The rising healthcare expenditure is expected to fuel the kcentra market going forward. Healthcare expenditure refers to the total spending on health services, including investments in medical infrastructure, advanced therapies, emergency care, and surgical interventions. Rising healthcare expenditure is due to an aging population, chronic diseases, higher service prices, increased demand, technological advancements, rising drug costs, the COVID-19 impact, medical inflation, and income polarization. Healthcare expenditure for Kcentra is primarily allocated to treatments for urgent reversal of anticoagulant-induced bleeding, with significant costs associated with its use in critical care and hospital settings. For instance, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, rising healthcare expenditure is driving the kcentra industry.

Key Players In The Global Kcentra Market

Major companies operating in the kcentra market are CSL Behring

Global Kcentra Market Trends and Insights

The key trend in the kcentra market is the approval of new therapies such as balfaxar (human prothrombin complex concentrate), driving competitive advancements within the industry. Balfaxar is a therapy designed for the urgent reversal of acquired coagulation factor deficiency induced by warfarin therapy in adult patients requiring urgent surgery or invasive procedures. For instance, in July 2023, Octapharma USA, a US-based pharmaceutical company, announced that Balfaxar (prothrombin complex concentrate, human-lens, also known as octaplex in Europe and Canada) has been granted approval by the U.S. Food and Drug Administration (FDA) for the emergency reversal of acquired coagulation factor deficiency caused by vitamin K antagonist (VKA, such as warfarin) therapy in adult patients requiring urgent surgery or invasive procedures. Balfaxar works by restoring blood coagulation through replenishing the deficient clotting factors caused by warfarin therapy.

Regional Insights

North America was the largest region in the kcentra market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Kcentra Market?

The kcentra market consists of sales of profilnine, bebulin, and beriplex. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Kcentra Market Report 2026?

The kcentra market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the kcentra industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.